BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15814241)

  • 1. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
    Shah MH; Paradkar A
    Int J Pharm; 2005 Apr; 294(1-2):161-71. PubMed ID: 15814241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray dried glyceryl monooleate-magnesium trisilicate dry powder as cubic phase precursor.
    Shah MH; Biradar SV; Paradkar AR
    Int J Pharm; 2006 Oct; 323(1-2):18-26. PubMed ID: 16846704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices.
    Shah MH; Paradkar A
    Eur J Pharm Biopharm; 2007 Aug; 67(1):166-74. PubMed ID: 17353118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics.
    Rizwan SB; Hanley T; Boyd BJ; Rades T; Hook S
    J Pharm Sci; 2009 Nov; 98(11):4191-204. PubMed ID: 19340889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of multiparticulate vaginal tablet using glyceryl monooleate for sustained progesterone delivery.
    Biradar SV; Dhumal RS; Shah MH; Paradkar AR; Yamamura S
    Pharm Dev Technol; 2009; 14(1):38-49. PubMed ID: 18802845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices.
    Kumar M K; Shah MH; Ketkar A; Mahadik KR; Paradkar A
    Int J Pharm; 2004 Mar; 272(1-2):151-60. PubMed ID: 15019078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
    Lee KW; Nguyen TH; Hanley T; Boyd BJ
    Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Liquid Crystalline Systems Containing Antimicrobial Compounds on Infectious Skin Bacteria.
    Souza C; Watanabe E; Aires CP; Lara MG
    AAPS PharmSciTech; 2017 Aug; 18(6):2110-2119. PubMed ID: 28028794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems.
    Boyd BJ; Whittaker DV; Khoo SM; Davey G
    Int J Pharm; 2006 Feb; 309(1-2):218-26. PubMed ID: 16413980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cubic phase gels as drug delivery systems.
    Shah JC; Sadhale Y; Chilukuri DM
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):229-50. PubMed ID: 11311994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro peptide release from liquid crystalline buccal delivery systems.
    Lee J; Kellaway IW
    Int J Pharm; 2000 Feb; 195(1-2):29-33. PubMed ID: 10675679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic characterization of swelling of liquid crystalline phases of glyceryl monooleate.
    Lee J; Choi SU; Yoon MK; Choi YW
    Arch Pharm Res; 2003 Oct; 26(10):880-5. PubMed ID: 14609139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal Cubic Phases of Metformin Hydrochloride: In Silico and in Vitro Studies of Delivery Mechanisms.
    Yu X; Jin Y; Du L; Sun M; Wang J; Li Q; Zhang X; Gao Z; Ding P
    Mol Pharm; 2018 Aug; 15(8):3121-3132. PubMed ID: 29979604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Control Release; 2004 Sep; 99(2):217-29. PubMed ID: 15380632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyceryl monooleate-based otic delivery system of ofloxacin: release profile and bactericidal activity.
    Adwan S; Abu-Dahab R; Al-Bakri AG; Sallam A
    Pharm Dev Technol; 2015 May; 20(3):361-6. PubMed ID: 24392877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.
    Lai J; Chen J; Lu Y; Sun J; Hu F; Yin Z; Wu W
    AAPS PharmSciTech; 2009; 10(3):960-6. PubMed ID: 19636709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.